- Exchange: Tel Aviv
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for NASVAX Ltd (NSVX)
| Open: | 8.40 | Day's Range: | 7.40 - 8.10 | Volume: | 276,928 |
|---|---|---|---|---|---|
| Previous Close: | 8.40 | 52wk Range: | 7.40 - 65.00 | 1-Yr Rtn: | -86.92% |
Key Statistics for NSVX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. TA-100 | - |
| Earnings Per Share (ttm) | -0.3232 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M ILS) | 6.88 |
| Shares Outstanding (M) | 90.57 |
| 30 Day Average Volume | 145,891 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NSVX
Company Profile & Key Executives for NSVX
NasVaX Ltd., is a biotechnology company. The Company develops improved vaccines and immunotherapeutic products.
| Elad NaggarChairman | Guy YachinChief Executive Officer |
| Dorit KreinerChief Financial Officer | Ronald W EllisSenior VP/CTO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NSVX News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page